The company acts as an intermediary and aggregator for paper mills, importing waste paper, pulp, and specialty chemicals from international markets to supply domestic manufacturers.
The company operates as a pure trading intermediary in a highly fragmented commodity market with no proprietary technology or brand power. Financial metrics contradict any moat claim, as net margins are near zero (0.3%) and revenue has collapsed by nearly 90% over a three-year period.
Capital has been primarily utilized to fund working capital for a shrinking trading business, with no significant reinvestment in productive assets. The recent period shows a massive liquidation of trade receivables and a shift toward related-party loans rather than business expansion.
The business likely collapsed as the core trading model reached its logical conclusion of irrelevance. Following a 90% revenue decline in just three years, the company likely failed to pivot from its role as a commodity intermediary. The massive customer concentration proved fatal when the top five clients, representing nearly all sales, found more efficient procurement channels. The sudden departure of the entire legacy board in 2025 signaled an internal realization that the business was no longer a going concern, leaving minority shareholders with a shell company that eventually liquidated its remaining receivables to settle promoter loans.
RichFakir rates Gautam Exim Ltd's business quality as poor — 27/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Gautam Exim Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Gautam Exim Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Gautam Exim Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →